CERA

Close Menu

Donate

Donate to CERA

Subscribe

Get monthly updates

Clinical trials

Take part in research
Close Close
Hope in sight TM

Our research is bringing hope to people affected by vision loss and blindness

Donate Now

What’s your vision for 2025?

Donate this festive season and join us on our mission to ensure people of all ages can continue to see and connect with the moments and people that matter most.

Video

15th Annual Crock Lecture
Watch pioneering ocular gene therapy researcher Professor Jean Bennett deliver an engaging and enlightening presentation on pioneering treatments for blinding retinal disorders for the 15th annual Gerard Crock Lecture.  

Hope in Sight Giving Day

THANK YOU
Thanks to your incredible support, we raised $187,607 to advance our research to find new treatments for eye diseases that cause vision loss and blindness. It’s research that could have a life-changing impact for people like Maggie, who lives with low vision from Usher Syndrome.

Consumer involvement

Help shape the future of vision research
Our new Consumer Program is working alongside people with lived experience to ensure their insights are at the heart of advancing eye research. Learn about the program and meet our Consumer Advisory Group.

Celebrating Cerulea Clinical Trials

Cerulea Clinical Trials, CERA’s new not-for-profit clinical trials centre, is up and running.
Learn how Cerulea will transform the delivery of ophthalmic clinical trials, increase community access to sight-saving therapies and deliver excellence for clinicians, trial participants and sponsors.

Read more

Take part in research

Help shape the future of vision research by taking part in a clinical study.
Find out how you can take part in studies at CERA and Cerulea Clinical Trials for eye conditions including age-related macular degeneration, corneal conditions, diabetic retinopathy, glaucoma and inherited retinal disease.

Learn more

Latest News
News

Boost for gene therapy start-up aiming to switch on sight

18 January 2025

A gene therapy start-up aiming to regenerate damaged eye cells to switch on sight has received a major funding boost to accelerate its research to treat blindness.
Research

Research: Sleep apnoea associated with age-related macular degeneration

04 December 2024

A Centre for Eye Research Australia study has linked low levels of oxygen in the blood overnight – a common sign of obstructive sleep apnoea – with wet age-related macular degeneration.
News

Precision medicine transforming treatment for corneal blindness

03 December 2024

CERA researchers have explored the potential of genetic analysis to transform how Fuchs’ endothelial corneal dystrophy is diagnosed and treated, with the hope of improving future outcomes for patients.
Research

New research shows potential of gene therapy to replace regular eye injections

31 October 2024

Australian scientists have successfully used an innovative gene therapy technique in the lab to combat a key cause of vision loss in ‘wet’ age-related macular degeneration and diabetic eye disease.

Eye-news emails are sent to subscribers once a month

Newsletter Subscribe
Receive Appeals